Inhibitory effect of membrane active compounds on induction of tyrosine aminotransferase in chick embryo liver cells in culture  by Epstein, Orit et al.
Volume 73, number 2 FEBS LETTERS February 1977 
INHIBITORY EFFECT OF MEMBRANE ACTIVE COMPOUNDS ON INDUCTION OF 
TYROSINE AMINOTRANSFERASE IN CHICK EMBRYO LIVER CELLS IN CULTURE 
Orit EPSTEIN, Nili SCHOENFELD and Abraham ATSMON 
The laboratory of Biochemical Pharmacology and The Department of Internal Medicine B, Beilinson Medical Center, 
Petah Tiqva and The Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel 
Received 19 October 1976 
1. Introduction 
In the course of investigations on the effect of 
beta-adrenergic receptor blocking agents in experimen- 
tal porphyria we observed an inhibitory action of 
DL-propranolol and other membrane active compounds 
on the induced activity of delta-aminolevulinate syn- 
thetase Q-ALAS) (EC 3.2.1.37) both in vivo and in 
vitro [l-3] . Beta-adrenergic receptor blocking 
agents compete with catecholamines for activation 
of beta-adrenergic receptors. Some of these agents 
also possess non-specific membrane effects such as 
changes in depolarisation and/or repolarisation of the 
cellular membrane, local anesthetic and anti-arhyth- 
mic properties, etc. Other drugs, which have no beta- 
receptor blocking effects, including quinidine and 
lydocain, have non-specific membrane activity and 
are regarded as membrane active compounds. The 
various membrane effects of these drugs and of beta- 
receptor blockers are, at least partially, dissimilar. 
In order to determine whethertheinhibitory 
effect of DL-propanolol and other membrane active 
compounds is specific for induction of &-ALAS, we 
examined their effect on induction of another induc- 
ible enzyme, tyrosine aminotransferase (TAT) 
(EC 2.6.1 S). TAT is a soluble enzyme, the activity 
of which is increased by administration of steroid 
hormones with glucocorticoid activity, both in rat 
liver [4] and in hepatoma cells in culture [5,6]. 
Dexamethasone is known to be a potent inducer in 
cultured hepatoma cells. It raises TAT activity 4-8 
fold in this system [7,8]. Our experiments were 
carried out in cultures of chick embryo liver cells. 
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2. Materials and methods 
Preparation and premilinary incubation of cultures 
of chick embryo liver cells in Eagle’s essential mini- 
mal medium with 10% fetal calf serum were carried 
out as described by Granick [9]. 
Since fetal calf serum may contain hormones or 
other substances capable of affecting enzyme activity 
the actual experiments were performed in essential 
minimal medium without addition of serum. Serum 
free medium containing the inducer and the experi- 
mental drugs was added to the cultures 18 h before 
determination of the activity of TAT. 
The fraction containing the enzyme was prepared 
from the monolayer cultures by the method of 
Whitlock et al. [7] with slight modifications: after 
discarding the culture medium containing inducer and 
test substances, the monolayer was washed twice 
with 3 ml 0.05 M phosphate-buffered saline (pH 7.4). 
Cells from 3 petri dishes (9 cm diameter each) were 
scraped off and collected in 5 ml cold phosphate- 
buffered saline. After centrifugation for 10 min, 
3000 X g, at 4’C, the pellet was homogenized in 1 ml 
of 0.2 M potassium phosphate buffer, pH 7.6. Ali- 
quots of 0.01 ml of the homogenate were removed 
for protein determination according to Lowry et al. 
[lo] . After a second centrifugation as above, TAT 
activity was determined in 0.2 ml of the supernatant 
according to Diamondstone [ 1 l] . In short, the frac- 
tion of supernatant containing the soluble enzyme is 
incubated in the presence of tyrosine and cw-ketoglu- 
tarate, forming p-hydroxy-phenylpyruvate. At a basic 
pH the latter is converted into p-hydroxy benzaldehyde, 
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Fig.1. The effect of dexamethasone on activity of tyrosine 
-f aminotransferase in cultured chick embryo liver cells. Chick 
embryo liver cells were incubated in serum free medium in 
the presence of various concentrations of dexamethasone. 
After 18 h incubation at 37°C the activity of tyrosine amino- 
transferase was determined (See Materials and methods). 
Values are expressed as nmoles p-hydroxybenzaldehyde 
produced /30 min/mg protein. 
which is measured spectrophotometrically. TAT activ- 
ity is expressed as nmoles p-hydroxybenzaldehyde 
produced during 30 min incubation at 37”C/mg 
protein. 
Dexamethasone, 2 X 10e6 M was found to be the 
optimal concentration in this system as shown in fig.1. 
0 0.5 1.0 20 3.0 4.0 
Dexametharone (PM) 3. Results 
Results are summarized in table 1. DL-propranolol 
and oxoprenolol, both beta-adrenergic blocking agents 
Table 1 
The effect of beta-adrenergic blocking agents and membrane active compounds on basal and 
induced activity of tyrosine aminotransferase in chick embryo liver cells in culture 
Drug 
Beta-adrenergic blocking agents 
with non-specific membrane ffects 
DL-propranolol 
Oxprenolol (Trasicor) 
Concentration 
&g/ml) 
60 
150 
300 
% Decrease in activity of 
tyrosine aminotransferase 
non-induced cells induced cells 
2.2 f 2.2 69 + 9.5 
36.5 f 9.6 
5.5 f 1.5 67.6 + 11.1 
Beta-adrenergic blocking agents 
without membrane ffects 
F’indolol (Visken) 
Bract0101 
30 2.8 f 2.7 5.9 f 5.9 
150 3.3 * 2.0 6.4 f 5.1 
Membrane active compounds 
Dpropranolol 
Quinidine sulfate 
Lydocain 
60 12.4 f 11.9 69.5 f 0.5 
50 6.0 + 4.0 67.1 * 3.9 
500 2.5 + 2.4 54.4 + 12.3 
Cultures were prepared as described in Materials and methods. Cells were incubated for 18 h with or 
without dexamethasone 2 X low6 M, in the absence (controls) or presence of various drugs and the 
activity of TAT was determined. The values obtained in control experiments, i.e., with or without 
dexamethasone but without addition of the various drugs examined, were considered as 100%. Aver- 
age activity of TAT in non-induced cells (without dexamethasone) was 15.7 * 6.7 nmolpHBA/30 min/ 
mg protein versus 38.5 ? 9.9 nmol pHBA/30 min/mg protein in induced cells. The effect of drugs on 
the activity of TAT was calculated as percent decrease in the enzyme activity when compared to the 
appropriate controls which were always performed simultaneously. 
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with non-specific membrane effects, inhibited induced 
TAT activity by 65-70%. Practolol and pindolol, 
both beta-adrenerglc blocking agents devoid of mem- 
brane properties, did not affect induced TAT activity. 
Membrane active compounds, D-propranolol, quinidine 
and lydocain reduced the induced activity by 50-70%. 
The concentration of all drugs was chosen accord- 
ing to their potency as beta-adrenergic blocking or 
membrane active compounds, compared to DLpropra- 
nolo1 and quinidine. All the drugs tested did not sig- 
nificantly affect the activity of the non-induced 
enzyme. 
4. Discussion 
The induction of TAT is thought to be under post- 
transcriptional control [ 121. Increased TAT activity 
is apparently the result of increased synthesis of 
tyrosine aminotransferase and not of any alteration 
in enzyme activity or decay [13,14]. 
The induction of F-ALAS is also thought to be 
caused by increased synthesis of the enzyme [ 15,161. 
According to our results the membrane-active com- 
pounds examined partially inhibit induction of 
tyrosine amlnotransferase and of 6-ALAS [2,3]. These 
observations may be explained by assuming an inhib- 
itory effect of membrane-active compounds on 
protein synthesis. Further investigations to test this 
hypothesis are in progress in our laboratory. 
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